Richard C. Rosenzweig - 10 Oct 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Signature
/s/ Jessica Nielsen Causey, Attorney-In-Fact for Richard C. Rosenzweig
Issuer symbol
XRAY
Transactions as of
10 Oct 2025
Net transactions value
+$970
Form type
4
Filing time
15 Oct 2025, 16:52:43 UTC
Previous filing
15 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROSENZWEIG RICHARD C EVP, Corp Dev, GC & Secretary C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE /s/ Jessica Nielsen Causey, Attorney-In-Fact for Richard C. Rosenzweig 15 Oct 2025 0001206725

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +766 +0.91% $0.000000 85,184 10 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Award $970 +81 +1.3% $11.98 6,143 10 Oct 2025 Common Stock 81 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Richard C. Rosenzweig is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
F3 Comprised of phantom stock acquired as a result of accrued dividends.